Adage Capital Partners Gp, L.L.C. Biomea Fusion, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,100,000 shares of BMEA stock, worth $8.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,100,000Holding current value
$8.64 Million% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding BMEA
# of Institutions
120Shares Held
17.9MCall Options Held
978KPut Options Held
286K-
Cormorant Asset Management, LP Boston, MA3.57MShares$28 Million1.24% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$18.4 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$16.6 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$10.9 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$6.27 Million1.57% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $230M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...